Group Protests India State's Ban On Exporting Drugs Through Mail
This article was originally published in PharmAsia News
Executive Summary
The February ban by the FDA of India's state of Maharashtra on exporting drugs through the postal system has been costly to its drug makers at the rate of $675,000 a day, according to an Internet-based pharma group.